Clinical Trials

  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    3 takeaways from ADA

    Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.

    By • June 8, 2026
  • A Grail employee in white coat and blue gloves works with a blood sample.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    At ASCO, Grail points to positive signals in MCED data

    Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more evidence is needed before it is incorporated into screening guidelines.

    By • June 2, 2026
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers, AiM team up; Procept completes study enrollment

    Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept finished enrollment in a study of its aquablation treatment in prostate cancer.

    By • May 28, 2026
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic data back renal denervation in the long term

    Analyses presented at EuroPCR assessed Medtronic’s Symplicity blood pressure procedure in patient groups with severe hypertension and who had prior cardiovascular events.

    By • May 20, 2026
  • A catheter device is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific posts positive data for coronary IVL catheter

    With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.

    By • May 19, 2026
  • An image of a GI robot.
    Image attribution tooltip
    Permission granted by Neptune Medical
    Image attribution tooltip

    Neptune Medical’s GI robot succeeds in colonoscopy study

    The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the beginning of the large intestine.

    By • May 6, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s Ottava robot meets goals in gastric bypass study

    The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.

    By • May 6, 2026
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet starts study of closed loop insulin delivery system

    Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

    By • May 4, 2026
  • A picture of a blue pulsed field ablation catheter against a gray background.
    Image attribution tooltip
    Courtesy of Johnson & Johnson MedTech
    Image attribution tooltip

    J&J starts head-to-head PFA trial against Boston Scientific device

    The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.

    By • April 28, 2026
  • Boston Scientific's Farawave pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    4 studies to know from HRS 2026

    Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where market share shifts in pulsed field ablation were on analysts’ minds.

    By • April 27, 2026
  • A modern two-story commercial office building with a mix of gray and wood paneling on the exterior. Large glass windows dominate both floors, and the front entrance features the "Medtronic" logo above double glass doors. The surrounding area includes a few small shrubs and empty parking spaces in front.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtronic confirms paclitaxel balloon’s efficacy in post-approval trial

    The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.

    By • April 16, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    VDyne secures FDA nod to start pivotal trial for tricuspid valve

    With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.

    By • April 6, 2026
  • Johnson & Johnson's Impella CP heart pump is shown in an illustration of the heart.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s Impella heart pump shows no patient benefit in 2 trials

    Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat heart attack patients who don’t have cardiogenic shock.

    By • April 1, 2026
  • Medtronic's Symplicity Spyral device is shown against a white background.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to study renal denervation combined with PCI

    Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.

    By • March 31, 2026
  • A rendering of a rounded device with a wire structure surrounded by mesh.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific posts positive stroke prevention data for Watchman

    The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and efficacy goals in the closely watched CHAMPION-AF study.

    By • March 30, 2026
  • A rectangular, metallic device on a catheter sites next to three nickels.
    Image attribution tooltip
    Permission granted by Glucotrack
    Image attribution tooltip

    Glucotrack plans US trial of implantable glucose monitor this year

    Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.

    By • March 27, 2026
  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher completes $8.9B buyout of Clario

    Thermo Fisher plans to create a fast-growing business by integrating Clario’s data capture and management system with its existing capabilities.

    By • March 25, 2026
  • Professional photo of Ashley McEvoy
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet posts clinical data on fully closed-loop insulin delivery system

    The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

    By • March 12, 2026
  • Close up of a knee implant, showing the stem, which includes a gray extension.
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer Biomet shares smart knee data at AAOS

    The orthopedic firm published data showing patients with its Persona IQ implant had lower revision and physical therapy rates than those who received traditional knee implants.

    By • March 6, 2026
  • Medical professional explaining brain scan results
    Image attribution tooltip
    SDI Productions via Getty Images
    Image attribution tooltip
    Sponsored by Infineon

    Transforming epilepsy care: How innovative implantable neurotechnology offers new hope

    Minimally invasive brain stimulation may be the new frontline treatment for drug-resistant patients.

    Feb. 23, 2026
  • Test tube blood
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Grail’s multi-cancer early detection test misses study goal

    Shares in the company lost about half their value in Friday trading after the clinical trial failed to demonstrate a statistically significant reduction in Stage III and IV cancers.

    By • Feb. 20, 2026
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    4 takeaways from the 2026 AF Symposium

    Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.

    By • Feb. 10, 2026
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine

    Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.

    By • Feb. 9, 2026
  • FDA sign
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pulse Biosciences wins FDA approval to begin PFA catheter study

    Shorter, nanosecond pulses for treating atrial fibrillation differentiate the company’s approach from existing pulsed field ablation systems on the market.

    By • Dec. 18, 2025
  • AtriCure’s EnCompass Clamp device is shown against a white background.
    Image attribution tooltip
    Retrieved from AtriCure on December 12, 2025
    Image attribution tooltip

    AtriCure treats first patients with dual PFA/RF system

    Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

    By • Dec. 12, 2025